Eastman (EMN) Director Reports Purchase of 1,453 Shares at $68.8
Rhea-AI Filing Summary
Julie Fasone, a director of Eastman Chemical Company (EMN), purchased 1,453 shares of the company's common stock on 08/27/2025 at a reported price of $68.8 per share. After this purchase she beneficially owned 17,546 shares in a direct ownership capacity. The Form 4 was filed as a single reporting person filing and the form was signed on behalf of Ms. Fasone by Mark D. Austin by power of attorney on 08/28/2025. The report discloses no derivative transactions and provides no additional remarks.
Positive
- Director purchase reported, indicating direct insider acquisition of 1,453 shares
- Clear disclosure of post-transaction ownership: 17,546 shares held directly
- No derivatives involved, simplifying ownership picture
Negative
- None.
Insights
TL;DR: Routine insider purchase by a director; standard Form 4 disclosure with direct beneficial ownership increase.
The filing documents a common, straightforward acquisition by a board director. The purchase increases the director's direct shareholdings to 17,546 shares and is disclosed under Section 16(a). There are no derivative transactions, no amendments, and the filing was executed via power of attorney. For governance, this is a standard, transparent disclosure consistent with reporting obligations.
TL;DR: Insider purchase reported; transaction details are clear and routine, providing limited market-moving information.
The Form 4 reports acquisition of 1,453 common shares at $68.8 each on 08/27/2025, raising direct beneficial ownership to 17,546 shares. The absence of derivative activity and lack of explanatory remarks indicate a single open-market or plan purchase reported under the appropriate transaction code. The disclosure fulfills regulatory requirements but contains no additional material financial data.